rebamipide 2% ophthalmic suspension

DRUG3 trials

Sponsors

Kubota Vision Inc.

Conditions

Dry EyeDry Eye SyndromeDry Eye SyndromesKeratoconjunctivitis Sicca

Phase 2

Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry Eye

CompletedNCT01027013

Kubota Vision Inc.Dry Eye Syndromes, Keratoconjunctivitis Sicca

Start: 2009-12-31End: 2010-11-30Updated: 2012-01-11

Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central Cornea

CompletedNCT01057147

Kubota Vision Inc.Dry Eye, Keratoconjunctivitis Sicca

Start: 2010-02-28End: 2011-02-28Updated: 2012-01-11

Phase 3

Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome

CompletedNCT01632137

Kubota Vision Inc.Dry Eye Syndrome

Start: 2012-06-30Updated: 2014-05-07